Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title | Funding Agency | Discipline | Who's Eligible |
Award Amount |
Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 9/14/2021 | NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $87,500,000 | 4/18/2022 |
| Deadline: 11/10/2020 | Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $18,000,000 | 4/18/2022 |
| Deadline: 4/03/2020 | Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $6,500,000 | 4/18/2022 |
| Deadline: 5/07/2021 | Congressionally Directed Medical Research Programs (CDMRP) -- Gulf War Illness Research Program -- Research Advancement Award | Department of Defense |
Discipline:
|
Who's Eligible:
|
Award Amount: $6,200,000 | 4/18/2022 |
| Deadline: 11/04/2020 | George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $5,000,000 | 4/18/2022 |
| Deadline: 5/29/2020 | Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $5,000,000 | 4/18/2022 |
| Deadline: 11/30/2020 | Maternal and Pediatric Precision in Therapeutics (MPRINT) Centers of Excellence in Therapeutics (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $4,250,000 | 4/18/2022 |
| Deadline: 7/28/2020 | Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $4,000,000 | 4/18/2022 |
| Deadline: 9/08/2021 | Congressionally Directed Medical Research Programs -- Neurotoxin Exposure Treatment Parkinson’s Program -- Synergistic Idea Award | Department of Defense |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,000,000 | 4/18/2022 |
| Deadline: 6/11/2021 | Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,000,000 | 4/18/2022 |
| Deadline: 7/15/2021 | Congressionally Directed Medical Research Programs -- Prostate Cancer Research Program -- Health Equity Research and Outcomes Improvement Consortium Award | Department of Defense |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,700,000 | 4/18/2022 |
| Deadline: 3/10/2022 | HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01, R34 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 6/05/2021 | NIAMS -- Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01, R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/08/2022 | Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 9/14/2021 | Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/09/2022 | The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 11/13/2020 | Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/10/2022 | HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 2/05/2020 | Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,250,000 | 4/18/2022 |
| Deadline: 4/01/2020 | Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,200,000 | 4/18/2022 |
